About Us
Our Company
Our Leadership
Precision Science
Power of GPCRs
Unique & Proprietary Approach
Our Programs
Partnerships
Our Partnerships
Our Partners
News & Media
Press releases
News
Media Highlights
Downloads
Careers
Search on our website
Type Enter to start searching.
Pipeline
Programs
Scroll to explore
Scroll back top
19 March 2025
Biased antagonist of PAR2
Discover more
9 March 2020
EP4 receptor antagonist
Discover more
9 March 2020
Anti-CCR8 depleting antibody
Discover more
26 February 2020
Undisclosed GPCR targets
Discover more